Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization

被引:17
|
作者
Allison, Robert D. [1 ]
Teleb, Nadia [2 ]
Al Awaidy, Salah [3 ]
Ashmony, Hossam [2 ]
Alexander, James P. [1 ]
Patel, Minal K. [1 ]
机构
[1] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E98, Atlanta, GA 30329 USA
[2] WHO, Eastern Mediterranean Reg Off, Cairo 11371, Egypt
[3] Minist Hlth, 18th November St, Muscat, Oman
关键词
Hepatitis B virus; HBV; Vaccination; birth dose; North Africa; Middle East; EMRO; INFANT IMMUNIZATION COVERAGE; VIRUS INFECTION; HOME DELIVERY; COLD-CHAIN; VACCINATION; TRANSMISSION; ELIMINATION; PROGRESS; IMPACT;
D O I
10.1016/j.vaccine.2016.03.063
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the pre-vaccination era, the prevalence of chronic hepatitis B virus (HBV) infection in the World Health Organization (WHO) Eastern Mediterranean Region (EMR) ranged from two to seven percent in a total population of over 580 million people. Mortality estimates place cirrhosis among the top ten causes of years of life lost in the EMR The region has made notable achievements, improving coverage from only 6% in 1992, when WHO recommended hepatitis B vaccination of all infants, to 83% in 2014. Member states adopted a hepatitis B control target in 2009 to reduce chronic hepatitis B virus infection prevalence to less than one percent among children aged <5 years by 2015. This report reviews progress toward achievement, challenges faced, and the next steps forward of hepatitis B control among children in the EMR. Published by Elsevier Ltd.
引用
收藏
页码:2403 / 2409
页数:7
相关论文
共 50 条